Home › NDC Lookup › RxCUI directory › RxCUI 2373460

Celecoxib 25 MG/ML Oral Solution [Elyxyb] — RxCUI 2373460

RxNorm drug concept · Semantic branded drug
RxCUI 2373460 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2373460
Official nameCelecoxib 25 MG/ML Oral Solution [Elyxyb]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asElyxyb 120 MG per 4.8 mL Oral Solution; Elyxyb 120 MG in 4.8 mL Oral Solution
FDA products mapped1
Package NDCs mapped2
Reported Medicaid activity (SDUD)1,575 prescriptions · 11 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Celecoxib: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It depends on the product. Celebrex and generic capsules are used for several types of arthritis, acute pain and painful periods. Vyscoxa liquid is for certain arthritis types. ELY...
  • For capsules, usual doses can be taken with or without food, but higher doses are taken with food. Vyscoxa suspension must be taken on an empty stomach, at least 2 hours before or...
  • The most common ones are stomach upset, indigestion, diarrhea, gas, swelling, dizziness, cold-like symptoms and rash. Call your doctor if they bother you or don't go away.
  • Get emergency help for chest pain, shortness of breath, weakness on one side, slurred speech, black or bloody stools, vomiting blood, or swelling of the face or throat. Stop it and...
📖 Read our full Celecoxib guide →

🕸️ Concept Web — How Celecoxib 25 MG/ML Oral Solution [Elyxyb] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Celecoxib 25 MG/ML Oral Solution [Elyxyb] RxCUI 2373460

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Celecoxib 140587
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Elyxyb 2373455
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Celecoxib Oral Solution 2373453
    • Celecoxib Oral Liquid Product 2373452
    • Celecoxib Oral Product 1161223
    • Celecoxib Oral Solution [Elyxyb] 2373457
    • Elyxyb Oral Liquid Product 2373458
    • Elyxyb Oral Product 2373459
    • Oral Solution 316968
    • Oral Liquid Product 1151137
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Celecoxib 25 MG/ML Oral Solution SCD · 2373454
  • Celecoxib 25 MG/ML SCDC · 2373451
  • Celecoxib Oral Solution SCDF · 2373453
  • Celecoxib Oral Liquid Product SCDG · 2373452
  • Celecoxib Oral Product SCDG · 1161223

Brand-Name Concepts

  • Celecoxib 25 MG/ML [Elyxyb] SBDC · 2373456
  • Celecoxib Oral Solution [Elyxyb] SBDF · 2373457
  • Elyxyb Oral Liquid Product SBDG · 2373458
  • Elyxyb Oral Product SBDG · 2373459
  • Elyxyb BN · 2373455

📦 FDA Products & Package NDCs

1 product · 2 package NDCs
2 package NDCs map to RxCUI 2373460 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
69557-0333-01 6 BOTTLE in 1 CARTON (69557-333-01) / 4.8 mL in 1 BOTTLE ELYXYB - celecoxib SCILEX PHARMACEUTICALS INC. 2023-11-27
69557-0333-02 1 BOTTLE in 1 CARTON (69557-333-02) / 4.8 mL in 1 BOTTLE ELYXYB - celecoxib SCILEX PHARMACEUTICALS INC. 2023-11-27
Observed labelers: SCILEX PHARMACEUTICALS INC. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ml · median
$30.5344
Range $30.5344–$30.5344 · middle 50% $30.5344–$30.5344 · 1 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.